The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real-world multicenter study.
Xiaochen FeiLiancheng FanWei ChenWei ChenYiming GongXinxing DuYanqing WangYinjie ZhuJiahua PanFangqin WangWanbing ZhaoTongtong LiuYining YangBaijun DongWei XuePublished in: Clinical and translational medicine (2022)